case review: mm with high-risk cytogenetics
Published 5 years ago • 185 plays • Length 2:42Download video MP4
Download video MP3
Similar videos
-
10:37
case 2: double refractory patient with high-risk cytogenetics
-
3:29
case 1: risk stratification models for myelofibrosis
-
3:23
a case of high-risk multiple myeloma
-
3:13
case review: standard-risk multiple myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
17:42
answers to case study 9 and 5 multiple choice questions
-
7:37
monitoring and managing immunosuppression in your long case - pass the racp clinical exam
-
6:50
case 2: molecular risk stratification in myeloma
-
3:51
can daratumumab overcome the negative prognostic impact of high-risk cytogenetics?
-
4:11
multiple myeloma: a case review
-
4:02
frontline treatment with rvd for multiple myeloma
-
55:48
hitting the bcma target in multiple myeloma
-
35:50
dr. paul richardson on novel approaches for treating multiple myeloma | dana-farber cancer institute
-
1:52:01
mm & plasma cell dyscrasia
-
37:46
current and future directions for novel therapy for multiple myeloma: paul g. richardson, md
-
4:37
case-based overview: newly diagnosed multiple myeloma
-
44:05
what are new treatment options for newly-diagnosed multiple myeloma patients? dr. paul g. richardson
-
27:16
diagnosis and therapy of cmml in 2015
-
38:34
selinexor, bortezomib, and dexamethasone versus bortezomib & dexamethasone in previously treated mm
-
58:41
update on diagnosis and therapy of plasma cell dyscrasias
-
44:44
2019 multiple myeloma symposium | novel and next generation therapy
-
1:02:04
clinical investigator perspectives: the most relevant new data sets and advances in multiple myeloma